Philippe Douville

Dr. Douville is a senior executive with significant entrepreneurial experience in the biotechnology and pharmaceutical industries. He is a founder and the Chief Executive Officer of Milestone Pharmaceuticals Inc. While at Milestone, he raised $17 million in several rounds of equity financing with leading life sciences venture capital firms in order to advance Milestone’s lead program from discovery to the clinic. Dr. Douville has been a Director on Milestone’s Board since its inception in 2005 and served as Chairman of the Board from 2011 to 2012.  Prior to Milestone Pharmaceuticals, he held the positions of CEO and Chief Business Officer at Galileo Genomics (later Genizon Biosciences), a population genomics company he co-founded. As the founding CEO, he negotiated Galileo’s seminal strategic alliance with Myriad Genetics that provided the company’s initial round of financing and subsequently, as Chief Business Officer, he played a key role in preparing the company for its successful $16 million Series A financing with VCs. After leaving Galileo in 2001, Dr. Douville was involved in advising other biotech start-ups in a consulting capacity. Dr. Douville obtained his Ph.D. in Neuroscience from McGill University in 1991 and later pursued post-doctoral research activities at the University of Zurich. He obtained an MBA from the HEC business school of the University of Montreal in 1997.